Cleared Traditional

K810412 - USCI CARDIOVASCULAR CATHETER

K810412 is the FDA 510(k) clearance for USCI CARDIOVASCULAR CATHETER by C.R. Bard, Inc.. It is a Class 2 Cardiovascular device (product code DQO) cleared through the Traditional 510(k) pathway after a 15-day FDA review.

K810412 · C.R. Bard, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1981
Decision
15d
Days
Class 2
Risk

K810412 is an FDA 510(k) clearance for the USCI CARDIOVASCULAR CATHETER. Classified as Catheter, Intravascular, Diagnostic (product code DQO), Class II - Special Controls.

Submitted by C.R. Bard, Inc. (Mchenry, US). The FDA issued a Cleared decision on March 5, 1981 after a review of 15 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1200 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all C.R. Bard, Inc. devices

Submission Details

510(k) Number K810412 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 18, 1981
Decision Date March 05, 1981
Days to Decision 15 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
110d faster than avg
Panel avg: 125d · This submission: 15d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQO Catheter, Intravascular, Diagnostic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQO Catheter, Intravascular, Diagnostic

All 290
Devices cleared under the same product code (DQO) and FDA review panel - the closest regulatory comparables to K810412.
ANGIOGRAPHY KIT
K821976 · Mallinckrodt Critical Care · Jul 1982
CORONARY INFUSION KIT
K820001 · Mallinckrodt Critical Care · Jan 1982
GANZ CORONARY REPERFUSION CATHETER
K803270 · American Edwards Laboratories · Mar 1981
PRESSURE MONITORING SET
K802945 · Norton Performance Plastics Corp. · Dec 1980
STERI-SLEEVE
K802629 · Cordis Corp. · Oct 1980
PACKAGE FOR MEDI-TRACE PHYSIOLOGICAL PRE
K801321 · Graphic Controls Corp. · Jun 1980